• XAV-939: Advanced Modulation of Wnt/β-Catenin and Epigene...

  2025-10-20

  Discover how XAV-939, a potent tankyrase inhibitor, enables innovative research on Wnt/β-catenin signaling and epigenetic regulation. This article uniquely explores cross-talk with neuroinflammatory and osteogenic pathways, offering insights beyond conventional cancer and fibrosis models.

• Oseltamivir Acid: Bridging Antiviral Innovation and Precl...

  2025-10-19

  Explore how Oseltamivir acid, a powerful influenza neuraminidase inhibitor, is catalyzing advances in antiviral drug development and oncology by leveraging new preclinical models. Uncover unique insights into species-specific metabolism, resistance, and translational strategies for influenza antiviral research.

• LGK-974: Precision PORCN Inhibition for Advanced Wnt-Driv...

  2025-10-18

  Explore how LGK-974, a potent and specific PORCN inhibitor, is transforming Wnt-driven cancer research through unparalleled selectivity and innovative mechanistic insights. This article uniquely examines LGK-974’s advanced applications in challenging cancer models and its synergy with emerging therapeutic strategies.

93 records 7/7 page Previous First page 上5页 67